Published in Gene Therapy Weekly, May 6th, 2004
Scientists in England "recently described a novel, stable human immunodeficiency virus type 1 (HIV-1) vector packaging system, STAR. High-titer HIV-1 vectors bearing gammaretrovirus envelopes (Env) are continuously produced from STAR cells."
In their subsequent study, B.L. Strang and coauthors at University College London compared "the properties of such vectors, with the amphotropic murine leukemia virus (MLV-A) Env, a modified gibbon ape leukemia virus (GALV) Env and two modified versions of the cat endogenous retrovirus RD114 Env, produced from STAR...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.